These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12902116)

  • 1. Methotrexate in acute persistent humoral rejection: an option for graft rescue.
    Bacal F; Sodré GL; Fernandes DA; Aiello VD; Stolf N; Bocchi E; Bellotti G
    Ann Thorac Surg; 2003 Aug; 76(2):607-10. PubMed ID: 12902116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute humoral rejection in an infant without risk factors after heart transplantation.
    Binsalamah ZM; Marcano J; Zea-Vera R; Tunuguntla H; Kearney DL; Heinle JS; Fraser CD; Mery CM
    J Card Surg; 2018 Feb; 33(2):126-128. PubMed ID: 29399877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune system modulation in the highly sensitized transplant candidate.
    Davidson BT; Donaldson TA
    Crit Care Nurs Q; 2004; 27(1):1-9. PubMed ID: 14974520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
    Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate pulse therapy in the treatment of recurrent acute heart rejection.
    Bourge RC; Kirklin JK; White-Williams C; Naftel DC; George JF; Morrow R; Tarkka M; Welborn JM
    J Heart Lung Transplant; 1992; 11(6):1116-24. PubMed ID: 1457434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
    Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L
    J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression for heart transplantation: where are we now?
    Kobashigawa JA; Patel JK
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):203-12. PubMed ID: 16568129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: successful outcome and rationale for its use.
    Das B; Shoemaker L; Recto M; Austin E; Dowling R
    J Heart Lung Transplant; 2008 Feb; 27(2):242-4. PubMed ID: 18267235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of persistent rejection with methotrexate in stable patients submitted to heart transplantation.
    Bacal F; Veiga VC; Fiorelli AI; Bellotti G; Bocchi EA; Stolf NA; Ramires JA
    Arq Bras Cardiol; 2000 Feb; 74(2):141-8. PubMed ID: 10904287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection.
    Hosenpud JD; Hershberger RE; Ratkovec RR; Hovaguimian H; Ott G; Cobanoglu A; Norman D
    J Heart Lung Transplant; 1992; 11(4 Pt 1):739-45. PubMed ID: 1498141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart transplantation].
    Hetzer R; Warnecke H; Schüler S; Süthoff U; Wonigeit K; Lang W; Herrmann G; Hepp A; Schaps D; Borst HG
    Internist (Berl); 1985 Sep; 26(9):563-8. PubMed ID: 3905678
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed cellular and humoral acute rejection in elective biopsies from heart transplant recipients.
    Zeglen S; Zakliczynski M; Wozniak-Grygiel E; Nozynski J; Laszewska A; Wojarski J; Wojnicz R; Przybylski R; Kucewicz-Czech E; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3202-5. PubMed ID: 19857710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing pattern of humoral rejection in cardiac transplant recipients.
    Almuti K; Haythe J; Dwyer E; Itescu S; Burke E; Green P; Marboe C; Mancini D
    Transplantation; 2007 Aug; 84(4):498-503. PubMed ID: 17713434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart transplantation].
    Pavie A; Bonnet N; Leprince P; Barreda T
    Rev Prat; 2007 Feb; 57(3):287-93. PubMed ID: 17578029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
    Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
    J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and risk factors for heart transplantation in children with end-stage cardiomyopathy†.
    Alsoufi B; Kanter K; McCracken C; Kogon B; Vincent R; Mahle W; Deshpande S
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):85-92. PubMed ID: 25724907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.